• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SARS-CoV-2 感染显著增加了长期心血管风险。

SARS-CoV-2 infection markedly increases long-term cardiovascular risk.

机构信息

Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Largo A. Gemmelli 8, 00168 Rome, Italy.

Department of Cardiovascular Science, Catholic University School of Medicine, Largo Francesco Vito 1, 00168 Rome, Italy.

出版信息

Eur Heart J. 2022 May 21;43(20):1899-1900. doi: 10.1093/eurheartj/ehac168.

DOI:10.1093/eurheartj/ehac168
PMID:35362024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9383629/
Abstract

Comment on ‘Long-term cardiovascular outcomes of COVID-19’ which was published in . https://doi.org/10.1038/s41591-022-01689-3.

摘要

对发表于《柳叶刀》的文章《COVID-19 长期心血管结局》的述评。https://doi.org/10.1038/s41591-022-01689-3.

相似文献

1
SARS-CoV-2 infection markedly increases long-term cardiovascular risk.SARS-CoV-2 感染显著增加了长期心血管风险。
Eur Heart J. 2022 May 21;43(20):1899-1900. doi: 10.1093/eurheartj/ehac168.
2
Acute myocardial injury as a sole presentation of COVID-19 in patient without cardiovascular risk factors.急性心肌损伤作为无心血管危险因素患者中COVID-19的唯一表现。
Cardiol J. 2022;29(5):878-879. doi: 10.5603/CJ.2022.0083.
3
Editorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19.社论：SARS-CoV-2 感染一年后出现的心血管并发症与潜在心血管危险因素或 COVID-19 的严重程度无关。
Med Sci Monit. 2022 May 1;28:e937048. doi: 10.12659/MSM.937048.
4
Impact of the COVID‑19 pandemic on blood pressure control and cardiovascular risk profile in patients with hypertension.2019年冠状病毒病大流行对高血压患者血压控制和心血管风险状况的影响。
Pol Arch Intern Med. 2021 Oct 27;131(10). doi: 10.20452/pamw.16129.
5
The COVID Heart-One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks.新冠之心——SARS-CoV-2感染一年后，患者面临一系列心血管风险增加的情况。
JAMA. 2022 Mar 22;327(12):1113-1114. doi: 10.1001/jama.2022.2411.
6
Letter to the Editor: Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.致编辑的信：大邱广域市新冠肺炎住院患者心血管危险因素及心血管疾病对预后的影响
J Korean Med Sci. 2021 Apr 19;36(15):e113. doi: 10.3346/jkms.2021.36.e113.
7
[COVID-19 vaccine and anticoagulation patients at high cardiovascular risk. SEMERGEN recommendations].[新冠病毒疫苗与心血管疾病高风险的抗凝治疗患者。西班牙急诊与紧急情况协会（SEMERGEN）的建议]
Semergen. 2021 Jan-Feb;47(1):1-3. doi: 10.1016/j.semerg.2020.12.005. Epub 2021 Jan 2.
8
The COVID-19 pandemic: lifestyle and cardiovascular risk factors.新冠疫情：生活方式与心血管危险因素
Curr Opin Lipidol. 2021 Feb 1;32(1):71-73. doi: 10.1097/MOL.0000000000000725.
9
COVID-19 and cardiovascular risk: Flying toward a silent world?2019冠状病毒病与心血管风险：正飞向一个寂静的世界？
J Clin Hypertens (Greenwich). 2020 Oct;22(10):1945-1946. doi: 10.1111/jch.14019. Epub 2020 Sep 6.
10
Reduction in environmental noise during COVID-19 pandemic and cardiovascular disease: A mystery for further investigation.新冠疫情期间环境噪音的降低与心血管疾病：有待进一步研究的谜团。
J Clin Hypertens (Greenwich). 2020 Oct;22(10):1947-1948. doi: 10.1111/jch.14018. Epub 2020 Sep 3.

引用本文的文献

1
SARS-CoV-2 spike-induced syncytia are senescent and contribute to exacerbated heart failure.SARS-CoV-2 刺突诱导的合胞体是衰老的，并导致心力衰竭加重。
PLoS Pathog. 2024 Aug 5;20(8):e1012291. doi: 10.1371/journal.ppat.1012291. eCollection 2024 Aug.
2
Exposome in ischaemic heart disease: beyond traditional risk factors.外显子组与缺血性心脏病：超越传统危险因素。
Eur Heart J. 2024 Feb 7;45(6):419-438. doi: 10.1093/eurheartj/ehae001.
3
Elevated FAI Index of Pericoronary Inflammation on Coronary CT Identifies Increased Risk of Coronary Plaque Vulnerability after COVID-19 Infection.冠状动脉 CT 显示的冠周炎 FAI 指数升高可识别出 COVID-19 感染后冠状动脉斑块易损性增加的风险。
Int J Mol Sci. 2023 Apr 17;24(8):7398. doi: 10.3390/ijms24087398.
4
Low-density lipoprotein particles carrying proinflammatory proteins with altered aggregation pattern detected in COVID-19 patients 3 months after hospitalization.在COVID-19患者住院3个月后检测到携带促炎蛋白且聚集模式改变的低密度脂蛋白颗粒。
J Infect. 2023 May;86(5):489-492. doi: 10.1016/j.jinf.2023.02.024. Epub 2023 Feb 21.

本文引用的文献

1
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.长新冠：聚焦心血管的 COVID-19 后急性后遗症。
Eur Heart J. 2022 Mar 14;43(11):1157-1172. doi: 10.1093/eurheartj/ehac031.
2
The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury.新型冠状病毒肺炎心脏损伤的发病机制及长期后果
JACC Basic Transl Sci. 2022 Mar;7(3):294-308. doi: 10.1016/j.jacbts.2021.10.011. Epub 2022 Feb 9.
3
Long-term cardiovascular outcomes of COVID-19.COVID-19 长期心血管后果。
Nat Med. 2022 Mar;28(3):583-590. doi: 10.1038/s41591-022-01689-3. Epub 2022 Feb 7.
4
Cardiac involvement in the long-term implications of COVID-19.COVID-19 对心脏的长期影响。
Nat Rev Cardiol. 2022 May;19(5):332-341. doi: 10.1038/s41569-021-00631-3. Epub 2021 Oct 22.
5
Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study.瑞典 COVID-19 后急性心肌梗死和缺血性卒中的风险：一项自身对照病例系列和匹配队列研究。
Lancet. 2021 Aug 14;398(10300):599-607. doi: 10.1016/S0140-6736(21)00896-5. Epub 2021 Jul 29.
6
COVID-19 and Cardiovascular Disease: From Bench to Bedside.新型冠状病毒肺炎与心血管疾病：从基础到临床。
Circ Res. 2021 Apr 16;128(8):1214-1236. doi: 10.1161/CIRCRESAHA.121.317997. Epub 2021 Apr 15.
7
Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance.心血管磁共振评估恢复性肌钙蛋白阳性 COVID-19 患者的心肌损伤模式。
Eur Heart J. 2021 May 14;42(19):1866-1878. doi: 10.1093/eurheartj/ehab075.
8
Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study.新冠肺炎与季节性流感住院患者临床表现及死亡风险的比较评估：队列研究
BMJ. 2020 Dec 15;371:m4677. doi: 10.1136/bmj.m4677.
9
From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19.从血管紧张素转换酶 2 破坏到血栓炎症性微血管病：源自 COVID-19 的范例。
Int J Cardiol. 2021 Mar 1;326:243-247. doi: 10.1016/j.ijcard.2020.11.016. Epub 2020 Nov 10.
10
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives.新型冠状病毒肺炎与心血管疾病：从基础机制到临床展望。
Nat Rev Cardiol. 2020 Sep;17(9):543-558. doi: 10.1038/s41569-020-0413-9. Epub 2020 Jul 20.